Impact of Body Mass Index on Surgical and Oncological Outcomes in Laparoscopic Total Mesorectal Excision for Locally Advanced Rectal Cancer after Neoadjuvant 5-Fluorouracil-Based Chemoradiotherapy
Aims. To evaluate the impact of body mass index (BMI) on the surgical outcome of laparoscopic total mesorectal excision (laTME) for locally advanced rectal cancer (LARC, clinically staged as UICC stage II/III) after neoadjuvant chemoradiotherapy (nCRT). Methods. 312 LARC patients undergoing laTME af...
Saved in:
Main Authors: | Yanwu Sun, Pan Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/1509140 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction model construction for the occurrence of LARS after neoadjuvant therapy combined with laparoscopic total mesorectal excision in male patients with mid-low rectal cancer
by: Deng-Chao Wang, et al.
Published: (2024-12-01) -
Total neoadjuvant therapy followed by total mesorectal excision for rectal cancer in older patients real world data and proof of concept
by: Isacco Montroni, et al.
Published: (2024-11-01) -
Long-term outcomes of S-1 and oxaliplatin neoadjuvant chemotherapy with total mesorectal excision and lateral lymph node dissection for rectal cancer
by: Hajime Morohashi, et al.
Published: (2024-12-01) -
Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer
by: Meng Zhuang, et al.
Published: (2024-09-01) -
Evolution of transanal total mesorectal excision according to the IDEAL framework
by: Willem A Bemelman, et al.
Published: (2019-07-01)